Cargando…

The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation

To evaluate the effect of preoperative serum alpha-fetoprotein(AFP) level to total tumor volume (TTV) ratio as a prognostic marker on predicting the tumor recurrence and overall survival time of patients with hepatocellular carcinoma (HCC) after liver transplantation. One-hundred eight patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tao, Zhang, Xiao-shi, Pan, Fei, Lyu, Shao-cheng, Wang, Jing, Huang, Meng-xiu, He, Qiang, Lang, Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257855/
https://www.ncbi.nlm.nih.gov/pubmed/34190174
http://dx.doi.org/10.1097/MD.0000000000026487
_version_ 1783718392498225152
author Jiang, Tao
Zhang, Xiao-shi
Pan, Fei
Lyu, Shao-cheng
Wang, Jing
Huang, Meng-xiu
He, Qiang
Lang, Ren
author_facet Jiang, Tao
Zhang, Xiao-shi
Pan, Fei
Lyu, Shao-cheng
Wang, Jing
Huang, Meng-xiu
He, Qiang
Lang, Ren
author_sort Jiang, Tao
collection PubMed
description To evaluate the effect of preoperative serum alpha-fetoprotein(AFP) level to total tumor volume (TTV) ratio as a prognostic marker on predicting the tumor recurrence and overall survival time of patients with hepatocellular carcinoma (HCC) after liver transplantation. One-hundred eight patients with HCC who underwent liver transplantation in Beijing Chaoyang Hospital from April 2013 to October 2017 were studied. Divided into AFP/TTV≤2 group and AFP/TTV>2 group by the best cut-off score calculated by receiver operation characteristic curve, the clinical and pathological data of the patients in two groups were compared to explore the relationship between AFP/TTV and tumor recurrence together with the prognosis of HCC patients after liver transplantation. Risk factors of early tumor recurrence and poor prognosis of HCC in patients after liver transplantation were studied by multivariate regression analysis. Kaplan-Meier survival analysis was used to compare the tumor-free survival and overall survival between the two groups of patients. In 108 patients, 47 patients have AFP/TTV≤2 while 61 patients have AFP/TTV>2. Patients in AFP/TTV≤2 group have longer tumor-free survival time and overall survival time compared with patients in AFP/TTV>2 group. The age, total bilirubin level, serum AFP level, TTV, portal vein tumor thrombus and AFP/TTV (all P < .05) of patient with HCC are closely related to poor prognosis after liver transplantation. Multivariate regression analysis showed that have portal vein tumor thrombus (hazard ratio [HR] = 2.345, P < .05), TTV≥65.5 cm(3) (HR = 2.701, P < .05) and AFP/TTV > 2 (HR = 4.624, P < .05) are independent risk factors for poor prognosis of patients with HCC after liver transplantation while TTV≥65.5 cm(3) (HR = 2.451, P < .05) and AFP/TTV > 2 (HR = 4.257, P < 0.05) were independent risk factors for tumor recurrence at the same time. The tumor recurrence and the prognosis of patients with HCC after liver transplantation is affected by many factors. AFP/TTV ratio has important predictive value for the tumor recurrence and the prognosis of patients with HCC after liver transplantation. AFP/TTV>2 is an independent risk factor for both early tumor recurrence and poor prognosis of patients with HCC after liver transplantation.
format Online
Article
Text
id pubmed-8257855
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-82578552021-07-08 The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation Jiang, Tao Zhang, Xiao-shi Pan, Fei Lyu, Shao-cheng Wang, Jing Huang, Meng-xiu He, Qiang Lang, Ren Medicine (Baltimore) 4500 To evaluate the effect of preoperative serum alpha-fetoprotein(AFP) level to total tumor volume (TTV) ratio as a prognostic marker on predicting the tumor recurrence and overall survival time of patients with hepatocellular carcinoma (HCC) after liver transplantation. One-hundred eight patients with HCC who underwent liver transplantation in Beijing Chaoyang Hospital from April 2013 to October 2017 were studied. Divided into AFP/TTV≤2 group and AFP/TTV>2 group by the best cut-off score calculated by receiver operation characteristic curve, the clinical and pathological data of the patients in two groups were compared to explore the relationship between AFP/TTV and tumor recurrence together with the prognosis of HCC patients after liver transplantation. Risk factors of early tumor recurrence and poor prognosis of HCC in patients after liver transplantation were studied by multivariate regression analysis. Kaplan-Meier survival analysis was used to compare the tumor-free survival and overall survival between the two groups of patients. In 108 patients, 47 patients have AFP/TTV≤2 while 61 patients have AFP/TTV>2. Patients in AFP/TTV≤2 group have longer tumor-free survival time and overall survival time compared with patients in AFP/TTV>2 group. The age, total bilirubin level, serum AFP level, TTV, portal vein tumor thrombus and AFP/TTV (all P < .05) of patient with HCC are closely related to poor prognosis after liver transplantation. Multivariate regression analysis showed that have portal vein tumor thrombus (hazard ratio [HR] = 2.345, P < .05), TTV≥65.5 cm(3) (HR = 2.701, P < .05) and AFP/TTV > 2 (HR = 4.624, P < .05) are independent risk factors for poor prognosis of patients with HCC after liver transplantation while TTV≥65.5 cm(3) (HR = 2.451, P < .05) and AFP/TTV > 2 (HR = 4.257, P < 0.05) were independent risk factors for tumor recurrence at the same time. The tumor recurrence and the prognosis of patients with HCC after liver transplantation is affected by many factors. AFP/TTV ratio has important predictive value for the tumor recurrence and the prognosis of patients with HCC after liver transplantation. AFP/TTV>2 is an independent risk factor for both early tumor recurrence and poor prognosis of patients with HCC after liver transplantation. Lippincott Williams & Wilkins 2021-07-02 /pmc/articles/PMC8257855/ /pubmed/34190174 http://dx.doi.org/10.1097/MD.0000000000026487 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 4500
Jiang, Tao
Zhang, Xiao-shi
Pan, Fei
Lyu, Shao-cheng
Wang, Jing
Huang, Meng-xiu
He, Qiang
Lang, Ren
The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation
title The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation
title_full The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation
title_fullStr The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation
title_full_unstemmed The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation
title_short The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation
title_sort ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257855/
https://www.ncbi.nlm.nih.gov/pubmed/34190174
http://dx.doi.org/10.1097/MD.0000000000026487
work_keys_str_mv AT jiangtao theratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT zhangxiaoshi theratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT panfei theratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT lyushaocheng theratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT wangjing theratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT huangmengxiu theratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT heqiang theratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT langren theratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT jiangtao ratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT zhangxiaoshi ratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT panfei ratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT lyushaocheng ratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT wangjing ratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT huangmengxiu ratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT heqiang ratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation
AT langren ratioofpreoperativealphafetoproteinleveltototaltumorvolumeasaprognosticfactorofhepatocellularcarcinomaafterlivertransplantation